Solid Biosciences Inc

NASDAQ:SLDB  
3.79
+0.36 (+10.50%)
Products, Other Pre-Announcement

Solid Biosciences Announces FDA Lifts Clinical Hold On Ignite Dmd Clinical Trial

Published: 10/01/2020 11:49 GMT
Solid Biosciences Inc (SLDB) - Solid Biosciences Announces FDA Lifts Clinical Hold on Ignite Dmd Clinical Trial.
Solid Biosciences Inc - FDA Acknowledged That Company Satisfactorily Addressed All Clinical Hold Questions.
Solid Biosciences Inc - Working Diligently to Complete All Activities Necessary to Resume Dosing, Which Co Expects to Occur in Q1 of 2021.
Solid Biosciences Inc - Implemented and Shared With FDA Manufacturing Process Changes That Remove Majority of Empty Viral Capsids.
Solid Biosciences Inc - Reducing Maximum Weight of Next Two Patients Dosed to 18 Kg per Patient.